Evidence map›Paper›PMID 36559710›Full record

ArticlePolymers2022

Regeneration of Osteochondral Defects by Combined Delivery of Synovium-Derived Mesenchymal Stem Cells, TGF-β1 and BMP-4 in Heparin-Conjugated Fibrin Hydrogel.

Madina Sarsenova, Yerik Raimagambetov, Assel Issabekova, Miras Karzhauov, Gulshakhar Kudaibergen, Zhanar Akhmetkarimova, Arman Batpen, Yerlan Ramankulov, Vyacheslav Ogay

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. A review of advanced hydrogels for cartilage tissue engineering.Frontiers in bioengineering and biotechnology · 2024
    Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Madina SarsenovaStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.
Yerik RaimagambetovNational Scientific Center of Traumatology and Orthopedics Named after Academician N.D. Batpenov, Astana 010000, Kazakhstan.
Assel IssabekovaStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.
Miras KarzhauovStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.
Gulshakhar KudaibergenStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.ORCID 0000-0002-0779-4099
Zhanar AkhmetkarimovaStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.
Arman BatpenNational Scientific Center of Traumatology and Orthopedics Named after Academician N.D. Batpenov, Astana 010000, Kazakhstan.
Yerlan RamankulovStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.
Vyacheslav OgayStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.ORCID 0000-0001-5029-5255
National Center for Biotechnology · KZ

Funding

Ministry of Education and Science of the Republic of Kazakhstan OR11465426
6 · The paper itself

Abstract

The regeneration of cartilage and osteochondral defects remains one of the most challenging clinical problems in orthopedic surgery. Currently, tissue-engineering techniques based on the delivery of appropriate growth factors and mesenchymal stem cells (MSCs) in hydrogel scaffolds are considered as the most promising therapeutic strategy for osteochondral defects regeneration. In this study, we fabricated a heparin-conjugated fibrin (HCF) hydrogel with synovium-derived mesenchymal stem cells (SDMSCs), transforming growth factor-β1 (TGF-β1) and bone morphogenetic protein-4 (BMP-4) to repair osteochondral defects in a rabbit model. An in vitro study showed that HCF hydrogel exhibited good biocompatibility, a slow degradation rate and sustained release of TGF-β1 and BMP-4 over 4 weeks. Macroscopic and histological evaluations revealed that implantation of HCF hydrogel with SDMSCs, TGF-β1 and BMP-4 significantly enhanced the regeneration of hyaline cartilage and the subchondral bone plate in osteochondral defects within 12 weeks compared to hydrogels with SDMSCs or growth factors alone. Thus, these data suggest that combined delivery of SDMSCs with TGF-β1 and BMP-4 in HCF hydrogel may synergistically enhance the therapeutic efficacy of osteochondral defect repair of the knee joints.

Indexed as

BMP-4controlled releaseheparin-conjugated fibrin hydrogelosteochondral defectregenerationsynovium-derived mesenchymal stem cellsTGF-β1

Identifiers

PMID36559710
PMCPMC9780905
OpenAlexW4311723962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.